Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459283) titled 'The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors' on March 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd.
Condition:
Maligant Solid Tumor
Head & Neck Cancer
Thyroid Cancer
Lung Cancer - Non Small Cell Squamous
Breast Cancer
Sarcoma
Intervention:
Drug: INN805
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: April 2026
Target Sample Size: 10
Countries of Rec...